HighTower Advisors’s DarioHealth DRIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,111
Closed -$318K 3103
2020
Q4
$318K Hold
1,111
﹤0.01% 1895
2020
Q3
$372K Hold
1,111
﹤0.01% 1717
2020
Q2
$142K Hold
1,111
﹤0.01% 2065
2020
Q1
$150K Hold
1,111
﹤0.01% 1868
2019
Q4
$146K Hold
1,111
﹤0.01% 2034
2019
Q3
$136K Hold
1,111
﹤0.01% 2131
2019
Q2
$206K Hold
1,111
﹤0.01% 2044
2019
Q1
$328K Buy
+1,111
New +$330K ﹤0.01% 1680

Other funds holding DRIO

HighTower Advisors's DRIO Position: Q1 2021 in Review

HighTower Advisors sold out of DarioHealth (DRIO) in Q1 2021, closing a stake of 1,111 shares — an estimated $318K sold.

HighTower Advisors first reported a position in DRIO in Q1 2019 and held it in 8 quarters. The position peaked at $372K in Q3 2020. 54 funds tracked by Wall St. Rank hold DRIO as of Q1 2021.

  • HighTower Advisors reported no remaining DarioHealth position as of Q1 2021 after selling out during the quarter.
  • HighTower Advisors sold 1,111 DarioHealth shares in Q1 2021, an estimated $318K.
  • HighTower Advisors first reported a position in DarioHealth in Q1 2019 and held it in 8 quarters.
  • HighTower Advisors's DarioHealth position peaked at $372K in Q3 2020.
  • 54 funds tracked by Wall St. Rank held DarioHealth as of Q1 2021.

Based on HighTower Advisors's 13F filing for Q1 2021, filed 10 May 2021.